# Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia

> **NCT04785118** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 165 (actual)

## Conditions studied

- Vomiting

## Interventions

- **DRUG:** Hyoscine N Butylbromide
- **DRUG:** Ondansetron
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04785118
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04785118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04785118, "Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04785118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*